Biotech

All Articles

' Professional intuitiveness' led FDA specialists to support Zevra's unusual illness med

.Zevra Rehabs' unusual health condition medicine seems to become on the course to confirmation this ...

Pfizer takes $230M attacked after axing neglected DMD gene treatment

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) gene therapy failure has blown a $230 million op...

AC Immune finds 'landmark' prospective in Alzheimer's drug records

.After greater than twenty years of service neurodegenerative health conditions, Swiss biotech a/c I...

GSK drops ph. 2 HPV vaccine over absence of best-in-class prospective

.GSK has ditched a period 2 individual papillomavirus (HPV) vaccine from its own pipeline after deci...

OS Therapies refiles $6M IPO to finance HER2 drug, preclinical ADCs

.Operating system Therapies will definitely specify on the NYSE American inventory exchange today by...

ALX's fizzling CD47 response rate sends sell spiraling down

.ALX Oncology's phase 2 stomach cancer cells reaction rate has actually damaged. After viewing its o...

Ionis centers eye ailment from aim ats of Roche-partnered prospect after data disappoint

.Yet Another of Ionis Pharmaceuticals' essential midphase readouts has actually fallen short of desi...

Biogen's CEO claimed no risky deals in 2023. He's ready to become strong

.While Biogen's pharma peers are searching for late-stage resources along with little bit of risk, c...

Instil refills pipeline in $2B biobucks deal with ImmunOnco

.Instil Bio has actually been actually a biotech in search of a pipe after it scrapped its own lead ...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually handed back liberties to a very early Alzheimer's illness system to Denali Ther...